Vincenzo Rossi

Vincenzo Rossi has extensive work experience in the field of quality control and management. Vincenzo currently holds the position of Senior Quality Director & QP at ibi, a role they have held since November 2023. Prior to this, they were the Quality Director & QP at IBI - Istituto Biochimico Italiano Giovanni Lorenzini S.p.a. starting from February 2022. Vincenzo also has a significant tenure at Aenova Group, where they served as the Quality Lean Manager & QP from July 2018 to February 2022, and as the Quality Control Manager & QP from July 2009 to July 2018.

Vincenzo Rossi completed their undergraduate studies in Biologia, generale at Università degli studi la Sapienza di Roma from 1982 to 1988. Their education continued at Università degli Studi di Roma Sapienza, where they pursued a field of study in Microbiologia starting from 1990, but there is no specified end year or degree name for this program.

Location

Latina, Italy

Links

Previous companies


Org chart


Teams


Offices


IBI - Istituto Biochimico Italiano Giovanni Lorenzini S.p.a.

IBI (Istituto Biochimico Italiano G. Lorenzini Spa) is a leading international biopharmaceutical company that has been operating since 1918. Specializing in aseptic manufacturing of Injectable Medicinal Products, IBI has established direct commercial presence in the UK, Germany, and Italy, while also exporting through alliances to more than 20 countries worldwide, including the US, Australia, and Europe. IBI offers comprehensive CDMO services, including advanced formulation, process development, and GMP manufacturing of sterile finished products. Their expertise extends to developing solutions and freeze-dried powders for both chemical and biotech active ingredients, such as small molecules, monoclonal antibodies, recombinant proteins, oligonucleotides, and nanoparticle technologies. IBI is certified by FDA, AIFA (EU), EDQM, TGA. More information: www.ibi-lorenzini.com Business Development: bd@ibi-lorenzini.com • GMP production for biological medicinal products (active substance from CHO cell culture, peptides, monoclonal antibodies) • GMP production of sterile drug products • GMP production of sterile API and finished products • CDMO and GMP production for orals, topicals, injectables • Aseptic filling of injectable medicinal products • Micro and nanoparticles formulations aimed to delivery of different classes of active molecules • Pharmaceutical development • Analytical validations, stability testing • MA and IMP registration and Batch Release services • Investigational Medicinal Product production


Headquarters

Aprilia, Italy

Employees

201-500

Links